6846 iMDT Corner Hybrid video-assisted thoracoscopic surgery sleeve lobectomy for non-small cell lung cancer: a case report Chenlei Zhang1, Zhanwu Yu1, Jijia Li1, Peng Zu1, Pingwen Yu1, Gebang Wang1, Takuro Miyazaki2, Ryuichi Waseda3, Raul Caso4, Giulio Maurizi5, Hongxu Liu1 1Department of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China; 2Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan; 3Department of General Thoracic, Breast, and Pediatric Surgery, Fukuoka University, Fukuoka, Japan; 4Department of Surgery, MedStar Georgetown University Hospital, Washington, DC, USA; 5Department of Thoracic Surgery, Sant’Andrea Hospital, Sapienza University of Rome, Rome, Italy Correspondence to: Hongxu Liu. Department of Thoracic Surgery, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, No.44 Xiaoheyan Road, Dadong District, Shenyang 110042, China. Email:
[email protected]. Submitted Feb 04, 2020. Accepted for publication Oct 24, 2020. doi: 10.21037/jtd-20-2679 View this article at: http://dx.doi.org/10.21037/jtd-20-2679 Introduction procedure. Also, hybrid VATS SL is a safer approach, especially in patients with infiltration of the pulmonary Lung cancer continues to be the leading cause of cancer- artery (PA), as it makes the surgeon more comfortable related death in China and worldwide (1,2). Sleeve during the bronchial and arterial anastomoses. Literatures lobectomy (SL) and pneumonectomy are surgical options for have shown that hybrid VATS approach has advantages for the treatment of locally advanced non-small cell lung cancer select T3 chest wall lung cancers (13) and superior sulcus (NSCLC). SL was initially intended as a parenchyma- tumors (14) over conventional open surgery.